Pfizer eyes 400% price hike for Covid vaccine in private US market
fiercepharma.com
fiercepharma.com
One of the reasons for the increase, Pfizer said, is that it will provide vaccines in a single-dose vial as opposed to the current multi-dose vials. This change is because of “consumer preference,” Lukin said.
Not this:
it could add $2.5 billion to $3 billion in annual revenue for the company
https://www.news.com.au/technology/science/human-body/pfizer...
If the committee votes in favor, vaccine makers’ liability for injuries will transfer from the corporations to the federal government’s National Vaccine Injury Compensation Program (VICP) – effectively shifting the financial responsibility for the shots to the tax payer.
Pfizer and Moderna have so far been temporarily shielded from liability through the PREP Act, but that protection will end in 2023."